Mind Medicine (MindMed) Inc.
NASDAQ:MNMD
7.52 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 4.838 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0.527 | 0.79 | 0.8 | 0.814 | 0.805 | 0.803 | 0.8 | 0.8 | 0.78 | 0 | 3.263 | 3.263 | 1.179 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | -0.527 | 4.048 | -0.8 | -0.814 | -0.805 | -0.803 | -0.8 | -0.8 | -0.78 | 0 | -3.263 | -3.263 | -1.179 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0.837 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 14.645 | 11.178 | 10.756 | 13.203 | 14.777 | 12.599 | 8.83 | 7.772 | 9.326 | 10.241 | 34.789 | 7.071 | 4.667 | 5.759 | 8.157 | 5.342 | 2.7 | 1.803 | 0.425 |
| General & Administrative Expenses
| 9.813 | 10.499 | 10.659 | 8.413 | 14.407 | 8.263 | 5.07 | 9.211 | 7.617 | 8.264 | 59.065 | 12.941 | 28.509 | 7.231 | 9.003 | 1.541 | 2.501 | 1.983 | 1.055 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.77 | 0 | 0 | 0.77 | -1.599 | 0.601 | 0.686 | 0.312 | 0 |
| SG&A
| 9.813 | 10.499 | 10.659 | 8.413 | 14.407 | 8.263 | 5.07 | 9.211 | 7.617 | 8.264 | 59.065 | 12.941 | 28.509 | 8.001 | 7.404 | 2.142 | 3.187 | 2.295 | 1.055 |
| Other Expenses
| 0 | 0 | 0.051 | -0.051 | 0 | 0 | 0.001 | 0 | -0.007 | 0.036 | -74.652 | 0.152 | 0.099 | 1.179 | -0.413 | 0.138 | -0.03 | -2.142 | 0.138 |
| Operating Expenses
| 24.458 | 21.677 | 21.415 | 21.616 | 29.184 | 20.862 | 13.9 | 16.983 | 16.943 | 18.505 | 19.202 | 23.275 | 36.439 | 14.939 | 15.148 | 7.621 | 6.025 | 4.236 | 1.617 |
| Operating Income
| -24.458 | -22.204 | -22.205 | -21.616 | -29.184 | -23.531 | -13.9 | -16.983 | -16.943 | -18.469 | -93.834 | -23.24 | -36.472 | -15.011 | -12.574 | -7.618 | -6.359 | -3.577 | -1.615 |
| Operating Income Ratio
| 0 | 0 | -4.59 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 18.604 | -32.196 | -1.659 | 3.693 | -1.257 | -1.284 | 8.997 | 0.498 | -0.096 | 0.018 | -0.359 | 0.118 | 0.132 | 0.072 | 2.811 | -1.057 | 0.305 | -2.802 | -0.002 |
| Income Before Tax
| -5.854 | -54.4 | -23.864 | -17.923 | -29.13 | -24.815 | -4.903 | -16.485 | -16.957 | -18.451 | -94.193 | -23.144 | -36.301 | -14.845 | -12.512 | -8.675 | -5.717 | -7.033 | -1.617 |
| Income Before Tax Ratio
| 0 | 0 | -4.933 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0.484 | -1.824 | -0.791 | -0.054 | 2.669 | -8.997 | -0.498 | 0.007 | 0.027 | -1.157 | -0.109 | -0.177 | -0.188 | -0.226 | 1.054 | -0.645 | 3.451 | 0.002 |
| Net Income
| -5.854 | -54.4 | -23.864 | -17.923 | -29.13 | -27.484 | 4.094 | -15.987 | -16.957 | -18.478 | -93.036 | -23.144 | -36.301 | -14.845 | -12.512 | -8.675 | -5.717 | -7.033 | -1.617 |
| Net Income Ratio
| 0 | 0 | -4.933 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.081 | -1.14 | -0.59 | -0.45 | -0.76 | -0.72 | 0.11 | -0.55 | -0.6 | -0.66 | -3.32 | -0.83 | -1.34 | -0.57 | -0.48 | -0.46 | -0.33 | -0.52 | -0.084 |
| EPS Diluted
| -0.081 | -1.14 | -0.59 | -0.45 | -0.76 | -0.72 | 0.11 | -0.55 | -0.6 | -0.66 | -3.32 | -0.83 | -1.33 | -0.57 | -0.48 | -0.46 | -0.33 | -0.52 | -0.084 |
| EBITDA
| -24.458 | -21.677 | -21.415 | -21.616 | -27.137 | -20.862 | -21.054 | -16.331 | -16.034 | -17.689 | -98.922 | -19.978 | -33.209 | -13.832 | -12.987 | -7.481 | -6.222 | -3.439 | -1.478 |
| EBITDA Ratio
| 0 | 0 | -4.426 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |